Hyperuricemia: Clinical Trials

4 trials for Hyperuricemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Completed 3, Withdrawn 1

Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects
LC350189 200mg, Placebo, Moxifloxacin 400mg - Hyperuricemia, Gout
Early Phase 1CompletedLG Chem372021-09-232022-01-06
Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid.
Combination of Plant Extracts (BSL_EP026), Control - Hyperuricemia
Early Phase 1CompletedBiosearch S.A.342019-11-112020-05-13
Gender Differences in the Metabolic Effects of Uric Acid
low-fructose diet, Allopurinol - Hyperuricemia
Early Phase 1WithdrawnUniversity of Missouri-Columbia2017-03-032019-04-17
Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial
Treatment, Control - Hyperuricemia, Gout
Early Phase 1CompletedUniversity of Leeds222013-02-012015-03-24

Narrower conditions

Gout (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Kidney Calculi (1)

Broader conditions

Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Arthritis (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Crystal Arthropathies (2)  ·  Genetic Diseases, Inborn (2)  ·  Joint Diseases (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Purine-Pyrimidine Metabolism, Inborn Errors (2)  ·  Rheumatic Diseases (2)  ·  Calculi (1)  ·  Endocrine System Diseases (1)

Interventions

Allopurinol (1)  ·  Moxifloxacin (1)  ·  Tablets (1)  ·  Therapeutics (1)

Sponsors

Biosearch S.A. (1)  ·  LG Chem (1)  ·  University of Leeds (1)  ·  University of Missouri-Columbia (1)

Countries

United States (2)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Elizabeth Parks, PhD (1)  ·  Gary Williamson, PhD (1)  ·  Miguel Quesada, MD, PhD (1)  ·  Yuanlu Shi, PhD Candidate (1)